Huntington's Disease: The Most Curable Incurable Brain Disorder?

by Edward J. Wild
Published 2016-06-01

Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington's Disease.

by Filipe Brogueira Rodrigues, Lauren M Byrne, Peter McColgan, Nicola Robertson, Sarah J Tabrizi, Henrik Zetterberg, Edward J Wild
Published 2016-01-01

Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington's disease.

by Alexander J Lowe, Simon Sjödin, Filipe B Rodrigues, Lauren M Byrne, Kaj Blennow, Rosanna Tortelli, Henrik Zetterberg, Edward J Wild
Published 2020-01-01

Quantification of huntingtin protein species in Huntington's disease patient leukocytes using optimised electrochemiluminescence immunoassays.

by Davina J Hensman Moss, Nicola Robertson, Ruth Farmer, Rachael I Scahill, Salman Haider, Michela A Tessari, Geraldine Flynn, David F Fischer, Edward J Wild, Douglas Macdonald, Sarah J Tabrizi
Published 2017-01-01

Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington’s disease

by Zhen-Yi Andy Ou, Lauren M. Byrne, Filipe B. Rodrigues, Rosanna Tortelli, Eileanoir B. Johnson, Martha S. Foiani, Marzena Arridge, Enrico De Vita, Rachael I. Scahill, Amanda Heslegrave, Henrik Zetterberg, Edward J. Wild
Published 2021-02-01

Brain-derived neurotrophic factor in patients with Huntington's disease.

by Chiara Zuccato, Manuela Marullo, Barbara Vitali, Alessia Tarditi, Caterina Mariotti, Marta Valenza, Nayana Lahiri, Edward J Wild, Jenny Sassone, Andrea Ciammola, Anne Catherine Bachoud-Lèvi, Sarah J Tabrizi, Stefano Di Donato, Elena Cattaneo
Published 2011-01-01